| 1 |
What happens after randomised controlled trials? Uterine fibroids and ulipristal acetate: systematic review and meta-analysis of "real-world" data |
|
| | Neha Shah,Elizabeth Egbase,Michael Sideris,Funlayo Odejinmi | | | Archives of Gynecology and Obstetrics. 2021; | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Metastatic smooth muscle tumor of uncertain malignant potential after laparoscopic presuming myomectomy |
|
| | Marisa Tossamartvorakul,MarieChristine Valerie R. Mendoza,Kuan-Gen Huang,Shu-Han Chang | | | Gynecology and Minimally Invasive Therapy. 2021; 10(3): 187 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Hysteroscopic and ultrasonographic evaluation of ulipristal acetate treatment for symptomatic myomas in premenopausal women: a prospective study |
|
| | Pasquale De Franciscis,Antonio Schiattarella,Gaetano Riemma,Domenico Labriola,Domenico Ambrosio,Salvatore Giovanni Vitale,Antonio Cianci,Gaspare Cucinella,Gloria Calagna,Nicola Colacurci | | | Minimally Invasive Therapy & Allied Technologies. 2020; : 1 | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
Hormonal assessment of patients of reproductive age with uterine myoma for surgical treatment |
|
| | A. V. Kozachenko,Z. V. Revazova,L. V. Adamyan,T. A. Demura,N. V. Zaytsev | | | Medical Council. 2019; (13): 29 | | | [Pubmed] [Google Scholar] [DOI] | | | 5 |
Ulipristalacetat – aktueller Stellenwert in der Myombehandlung |
|
| | Thomas Römer | | | Gynäkologische Endokrinologie. 2019; | | | [Pubmed] [Google Scholar] [DOI] | |
|
